Tags
Swedish News Blog Blog

'Cancer Institute' Swedish News Blog posts

Swedish Cancer Institute Launches New Hematologic Malignancies Program

International hematology expert Dr. John Pagel recruited to expand Swedish’s treatment for, and research on, blood cancers

 

SEATTLE — September 8, 2014 — The Swedish Cancer Institute is launching a Hematologic Malignancies program for the expanded treatment and research of blood-based cancers such as leukemia, multiple myeloma and lymphoma. Newly recruited international hematology expert John Pagel, M.D., Ph.D., will serve as chief of the new program, which launches this month.
 
“Dr. Pagel brings with him a world-class reputation for research and excellence in patient care,” said Swedish Cancer Institute Executive Director Thomas Brown, M.D. “This new program will add to our existing strengths in caring for patients with hematologic malignancies and further develop our autologous hematopoietic stem cell program. These efforts allow the Swedish Cancer Institute to continue providing the most versatile and comprehensive cancer care in the Pacific Northwest.”
 
Dr. Pagel’s practice will include caring for patients with acute and chronic leukemias, multiple myeloma, Hodgkin and non-Hodgkin lymphomas, and myelodysplastic syndromes, as well as other myeloproliferative disorders. In addition to providing established treatments such as autologous stem cell transplants, the program will develop novel therapies for the treatment of blood-based diseases through research collaborations and studies initiated by Swedish Cancer Institute physicians.

Pacific Cancer Research Consortium Receives $6.6 Million Grant to Expand Access to Oncology Care, Trials

Consortium includes Swedish Cancer Institute, Providence Portland Medical Center and St. Luke’s Mountain States Tumor Institute

News Release
 
FOR IMMEDIATE RELEASE                                           
 
Contacts: Clay Holtzman, Swedish Cancer Institute, 206-386-2748, clay.holtzman@swedish.org
                  Jean Marks, Providence Portland Medical Center, 503-215-6433, jean.marks@providence.org
                  Ken Dey, St. Luke’s Mountain State Tumor Institute, 208-381-2894, deyke@slhs.org

SEATTLE — August 5, 2014 — The National Cancer Institute’s Community Oncology Research Program (NCORP) has awarded a consortium of  community cancer centers from the Western United States a five-year grant worth $6.6 million to improve access to lifesaving cancer care and clinical trials across a five-state region.
 
The Pacific Cancer Research Consortium is led by three primary sites: the Swedish Cancer Institute (SCI) in Seattle, which will serve as the grant’s fiduciary, Providence Portland Medical Center (PPMC) in Oregon and St. Luke’s Mountain States Tumor Institute (MSTI) in Boise, Idaho. The consortium also includes 37 other clinical care sites in Alaska, California, Idaho, Oregon and Washington. The program opened on Aug. 4.
 
The Consortium’s grant is part of a $93 million funding cycle announced today by NCORP and awarded to 53 researchers across the country.
 
“We are extremely honored that the National Cancer Institute Community Oncology Research Program has selected our consortium to lead the expansion of cancer clinical trials throughout the Western region,” said Thomas Brown, M.D., executive director of the Swedish Cancer Institute. “Together Swedish Cancer Institute, Providence Cancer Center at Providence Portland Medical Center, St. Luke’s Mountain States Tumor Institute, and a network of clinical care sites are giving patients and their families access to the most current investigational therapies that give hope to advancing the care of cancer patients throughout our region and beyond. Access to clinical trials is the key to providing high quality cancer care in the 21st century.”

Seattle Times Guest Column: What to do First When You Hear: ‘You Have Cancer’

In a guest column featured in the Sunday edition of the Seattle Times, Swedish Cancer Institute Medical Director for Naturopathic Services Dan Labrolia, N.D., provides expert advice to patients newly diagnosed with cancer.

In the piece, Labriola, who is also director of the Northwest Natural Health Specialty Clinic, provides direction on how to select a doctor, how to evaluate a treatment center and more.

Check out the first of Labriola’s three-part series here.

Swedish Medical Center Foundation Receives $10.1 Million Gift from The Robert and Jean Reid Family Foundation

With its largest gift, the Campaign for Swedish surpasses $128 million

 

News Release

FOR IMMEDIATE RELEASE   

Contact: Clay Holtzman, Swedish, 206-386-2748, clay.holtzman@swedish.org

SEATTLE – Dec. 11, 2013 – The Swedish Medical Center Foundation announced today that it is receiving a gift of $10.1 million from the estate of Robert and Jean Reid that will support advanced cancer and cardiac care at Swedish. Funds from the gift will be distributed to the Swedish Foundation over many years through The Robert and Jean Reid Family Foundation.

The gift — the largest made during the $100 million Campaign for Swedish — will help to establish a core component of the Swedish Cancer Institute’s (SCI) Personalized Medicine Program: The Robert and Jean Reid Family Innovative Therapeutics & Research Unit. The Reid Family Innovative Therapeutics & Research Unit will aim to evolve cancer detection, diagnosis and treatment through advanced clinical research. For example, Swedish will test patient genes to better understand how a cancerous tumor might respond to a specific treatment. This is one step toward personalizing treatments and improving patients’ lives and outcomes.

“The new Reid Family Innovative Therapeutics & Research Unit will help position SCI as a national and international thought leader in personalized, molecular-based cancer prevention and therapy,” said Dr. Thomas Brown, executive director of the Swedish Cancer Institute.

Swedish Ballard Offers Open House Tonight for Expanded Oncology and Treatment Center

The Ballard community is invited to a sneak peek of the new Swedish Cancer Institute (SCI) Medical Oncology and Treatment Center from 3:30 to 5:30 p.m. tonight - Tuesday, Nov. 12 - at Swedish Ballard, 5300 Tallman Ave. N.W., 2nd Floor.

Swedish Ballard has been providing cancer services to the community for more than 35 years. As a part of the continuing mission to provide world-class cancer care close to home, we are expanding our cancer treatment services at Ballard through the new Swedish Cancer Institute Medical Oncology and Treatment Center. This new space is an impressive 8,000+ square foot integrated facility that includes:

  • Clinic space for 5 medical oncologists
  • 13 infusions bays
  • 2 private rooms with hospital beds
  • Convenient, street-level access
  • Patient drop-off location

Medical oncologists and staff will be available to answer questions. We look forward to seeing you!

Swedish/Edmonds Announces Plans for Hospital Expansion; Addition Includes New Emergency Department, Urgent Care and Outpatient Imaging

EDMONDS, WASH., June 14, 2013 — Fulfilling a promise to the community to make significant investments in advanced medical services and technology, today Swedish/Edmonds announced plans for a $63.5 million expansion at the existing hospital campus. Construction of a two-story, 77,000-square-foot facility will feature a new emergency department (ED) with a dedicated behavioral health unit and urgent care center. It will also include a new outpatient diagnostic imaging center, observation unit, front entry, and parking garage. The building’s second floor will be reserved for future expansion of hospital services.  Construction is expected to begin in spring 2014, with completion of the ED and urgent care center in the fall of 2015.

Swedish Celebrates Dr. Saul Rivkin’s Long, Impressive Career as a Devoted, Accomplished Medical Oncologist and Researcher in Fight Against Ovarian Cancer



SEATTLE, June 6, 2013 – Swedish Cancer Institute (SCI) announced today that Saul Rivkin, M.D., medical oncologist, as well as founder and board chair of the Marsha Rivkin Center for Ovarian Cancer Research, will retire from his clinical practice at SCI on July 1, 2013. The highly respected and revered physician, who is 77 years old and has five daughters and seven grandchildren, Dr. Rivkin is best known for his committed, tenacious approach to fighting cancer and the personal connection he has established with the thousands of patients he has cared for over the years.

Results 1-7 of 73